Pharmaceuticals

Tue, 03/09/2010 - 14:44

Hua Xia Healthcare acquires Fujian drug distributor

Shanghai. March 9. INTERFAX-CHINA - Hong Kong Stock Exchange-listed Hua Xia Healthcare Holdings Ltd. announced on March 8 it has bought Huihao Medicine Group for RMB 600 million ($87.85 million).

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW